Sevion Therapeutics COO Gregory Williams' 2018 pay jumps 147% to $6M
Sevion Therapeutics reports 2018 executive compensation
By ExecPay News
Published: April 5, 2019
Sevion Therapeutics reported fiscal year 2018 executive compensation information on April 5, 2019.
In 2018, four executives at Sevion Therapeutics received on average a compensation package of $2.9M, a 12% increase compared to previous year.
Gregory Williams, Chief Operating Officer, received $6M in total. 94% of Williams' compensation, or $5.7M, was in option awards. Williams also received $50K in bonus, $78K in non-equity incentive plan, $245K in salary, as well as $10K in other compensation.
David P. Snow, Chief Business Officer, received a compensation package of $4.1M. 91% of the compensation package, or $3.8M, was in option awards.
Robert E. Ward, Chief Executive Officer, earned $904K in 2018, a 90% decrease compared to previous year.
Gregory Weaver, Chief Financial Officer, received $522K in 2018, which decreases by 67% compared to 2017.